The effect of smoking on peripheral insulin sensitivity and plasma endothelin level

Diabetes and Metabolism

Volumn 30, Issue 2, 2004, Pages 147-152

  Borissova, A M ^a   Tankova, T ^a   Kirilov, G ^a   Dakovska, L ^a   Krivoshiev, S ^b  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b UNIVERSITY HOSPITAL 'QUEEN GIOVANNA'   (Bulgaria)

Author keywords

Endothelin; Insulin receptors; Insulin sensitivity; Receptor affinity; Smoking

Indexed keywords

ENDOTHELIN; GLUCOSE; INSULIN; INSULIN RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; ARTIFICIAL PANCREAS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CIGARETTE SMOKING; FAMILY HISTORY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOXEMIA; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PERIPHERAL CIRCULATION; PROTEIN BLOOD LEVEL; RECEPTOR AFFINITY; RECEPTOR BINDING; SMOKING; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

EID: 2642536046     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70100-3     Document Type: Article

References (36)

1. Hirai N, Kawano H, Hirashima O, et al. Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol, 2000, 279, 1172-8.
2. Mayer-Davis EJ, Levin S, Bergman RN, et al. Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis study (IRAS). Diabetes Metab Res Rev, 2001, 17, 137-45.
3. Attvall S, Fowelin J, Lager I, et al. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med, 1993, 233, 327-32.
4. Binder C, Lauritzen T, Faber S, Pramming S. Insulin Pharmacokinetics. Diabetes Care, 1984, 7, 188-99.
5. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest, 1997, 27, 450-6.
6. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis, 1997, 129, 79-88.
7. Ronnemaa T, Ronnemaa EM, Puukka P, et al. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care, 1996, 19, 1229-32.
8. Targher G, Alberiche M, Zenere MB, et al. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1997, 82, 3619-24.
9. Nilsson PM, Lind L, Pollare T, et al. Increased level of hemoglobin Alc, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism, 1995, 44, 557-61.
10. Henkin L, Zaccaro D, Haffner S, et al. Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Ann Epidemiol, 1999, 9, 290-6.
11. Davis JW, Arnold J, Wiegmann P. Cigarette-smoking affects platelets and endothelium in chronic hemodialysis patients. Nephron, 1993, 64, 359-64.
12. Teuscher AU, Lerch M, Shaw S, et al. Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men. J Hypertens, 1998, 16, 1279-84.
13. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand, 1997, 161, 211-20.
14. Brock B, Gregersen S, Kristensen K, et al. The insulinotropic effect of endothelin-1 is mediated by glucagon release from the islet alpha cells. Diabetologia, 1999, 42, 1302-7.
15. Idris I, Patiag D, Gray S, Donnelly R. Tissue - and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake. Biochem Pharmacol, 2001, 62, 1705-8.
16. Anfossi G, Cavalot F, Massucco P. Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. Metabolism, 1993, 42, 1081-3.
17. Karet FE, Davenport AP. Endothelin and the human kidney: a potential target for new drugs. Nephrol Dial Transplant, 1994, 9, 465-8.
18. Saito Y, Nakao K, Makoyama M. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med, 1990, 322, 205.
19. Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictive peptide produced by vascular endothelial cells. Nature, 1988, 332, 411-5.
20. Goerre S, Staehli C, Shaw S, Luscher TF. Effect of cigarette smoking and nicotine on plasma endothelin-1 levels. J Cardiovasc Pharmacol, 1995, 26, S236-8.
21. Haak T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism, 1994, 43, 267-9.
22. Ahlborg G, Lundberg JM. Endothelin-1: increased plasma clearance, pulmonary affinity and renal vasoconstriction in young smokers. Clin Physiol, 2001, 21, 693-703.
23. Barua RS, Ambrose JA, Eales-Reynolds LJ, et al. Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation. J Am Coll Cardiol, 2002, 39, 1758-63.
24. DeFronzo RA, Tobin JD, Andres R. Glucose Clamp Technique: a method for quantifying insulin secretion and resistance. Am J Physiol, 1979, 237, E214-223.
25. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest, 1968, 21, 77-89.
26. Gavin JR, Roth J, Jen P. Insulin receptors in human circulating cells and fibroblasts. Proc Natl Acad Sci USA, 1972, 69, 747-51.
27. Doberne Z, Greenfield MS, Schultz B, Reaven GM. Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes, 1981, 30, 829-35.
28. Kahn CR. The molecular mechanism of insulin action. Ann Rev Med, 1985, 36, 429-51.
29. Hirata Y, Takagi Y, Fukuda Y. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis, 1989, 78, 225-8.
30. Mather K, Anderson TJ, Verma S. Insulin action in the vasculature: physiology and pathophysiology. J Vasc Res, 2001, 38, 415-22.
31. Ferri C, Carlomagno A, Coassin S, et al. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care, 1995, 18, 226-33.
32. Lee YC, Juan CC, Fang VS, et al. Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors. Metabolism, 1998, 47, 1468-71.
33. Anwaar I, Gttsater A, Eriksson K, et al. Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism. Diabetes Res Clin Pract, 2000, 50, 127-36.
34. Czernin J, Waldherr C. Cigarette smoking and coronary blood flow. Prog Cardiovasc Dis, 2003, 45, 395-404.
35. Asgeirsdottir LP, Agnarsson U, Jonsson GS. Lower extremity blood flow in healthy men: effect of smoking, cholesterol, and physical activity - a Doppler study. Angiology, 2001, 52, 437-45.
36. Mikkelsen KL, Wiinberg N, Hoegholm A, et al. Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens, 1997, 10, 483-91.